Zionsville, IN, United States of America

Rosanne Bonjouklian



Average Co-Inventor Count = 3.1

ph-index = 7

Forward Citations = 231(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1981 - 1994)
  • Zionsvill, IN (US) (2006)
  • Zionsville, IN (US) (1989 - 2011)

Company Filing History:


Years Active: 1981-2011

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Innovations and Achievements of Rosanne Bonjouklian

Introduction

Rosanne Bonjouklian, based in Zionsville, Indiana, is a notable inventor with an impressive portfolio of 19 patents. Her work primarily revolves around the development of kinase inhibitors, contributing significantly to the field of medicinal chemistry and pharmaceuticals.

Latest Patents

Among her latest contributions to innovation are the patent applications related to kinase inhibitors. The present invention provides kinase inhibitors of Formula I, showcasing her commitment to advancing therapeutic options for various diseases.

Career Highlights

Throughout her career, Rosanne has made substantial strides in her field while working with esteemed organizations such as Eli Lilly and Company and the Arizona Board of Regents, a Body Corporate. Her expertise and innovative mindset have led to significant advancements in biomedical research.

Collaborations

In her professional journey, Rosanne has collaborated with accomplished colleagues, including Michael LeRoy Phillips and Carlos Jaramillo Aguado. These partnerships have enhanced her research and contributed to successful patent applications, promoting collective innovation in the industry.

Conclusion

Rosanne Bonjouklian’s dedication to innovation and her noteworthy patent achievements exemplify her impact on the field of biotechnology. Her work not only exemplifies her personal accomplishments but also contributes to the broader scientific community, inspiring future inventors and researchers.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…